Vaccine Blockchain Plan Prompts Enquiries Amid China Pharma Scandal
Following China's pharma scandal, investors are buying into a firm's claim to be developing a vaccine-tracking blockchain, but not everyone is happy.
Following China's pharma scandal, investors are buying into a firm's claim to be developing a vaccine-tracking blockchain, but not everyone is happy.
Sebarkan Artikel Ini Y
